Back
Day Range
$29.13
$30.72
52-Week Range
$10.60
$31.82
Volume
732,161
50D / 200D Avg
$28.95
/
$19.99
Prev Close
$29.80
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -19.6 | 0.4 |
| P/B | 6.3 | 2.9 |
| ROE % | -34.2 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$38.67
+26.2%
Low: $25.00
High: $46.00
Forward EPS
-$2.09
Est. Revenue
2.3 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.31
$0.61 – $2.30
|
780 M | 5 |
| FY2029 |
-$0.77
-$1.35 – -$0.36
|
340 M | 2 |
| FY2028 |
-$1.72
-$2.31 – -$1.20
|
130 M | 7 |
Key Takeaways
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -143.82M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-34.19%
ROIC-27.28%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.01
Current Ratio19.85
Interest Coverage0.00
Valuation
P/E Ratio
-19.59
P/B Ratio6.29
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -167.80M |
| ROE | -34.19% | ROA | -30.36% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -143.82M |
| ROIC | -27.28% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 19.85 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -19.59 | P/B Ratio | 6.29 |
| P/S Ratio | N/A | PEG Ratio | -1.23 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.29B | Enterprise Value | 3.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -167.80M | -133.81M | -100.16M | -67.64M | -42.81M |
| EPS (Diluted) | -1.63 | -1.45 | -1.57 | -1.26 | -0.86 |
| Gross Profit | -2.27M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -191.41M | -158.83M | -114.36M | -71.66M | -43.22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 552.60M | 486.82M | 340.04M | 367.10M | 285.23M |
| Total Liabilities | 30.35M | 27.60M | 21.21M | 20.39M | 10.85M |
| Shareholders' Equity | 522.26M | 459.22M | 318.83M | 346.72M | 274.38M |
| Total Debt | 3.99M | 4.74M | 5.41M | 4.41M | 0.0 |
| Cash & Equivalents | 61.15M | 41.67M | 86.10M | 21.99M | 15.57M |
| Current Assets | 543.39M | 475.48M | 327.00M | 357.00M | 283.77M |
| Current Liabilities | 27.37M | 23.86M | 16.77M | 16.59M | 10.52M |